Geovax Labs Q2 2024 GAAP EPS $(1.99) Beats $(3.37) Estimate, Sales $301.000K
Portfolio Pulse from Benzinga Newsdesk
Geovax Labs (NASDAQ:GOVX) reported a Q2 2024 GAAP EPS of $(1.99), beating the analyst consensus estimate of $(3.37) by 40.95%. The company also reported $301,000 in sales for the quarter.
August 06, 2024 | 8:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Geovax Labs reported a Q2 2024 GAAP EPS of $(1.99), significantly beating the analyst consensus estimate of $(3.37). The company also reported $301,000 in sales for the quarter.
The significant beat on EPS estimates by 40.95% is a positive indicator for the company's financial health and could lead to a short-term increase in stock price. The reported sales of $301,000 also contribute positively.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100